Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Macrogenics (MGNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 930,722
  • Shares Outstanding, K 48,780
  • Annual Sales, $ 60,120 K
  • Annual Income, $ -171,450 K
  • 60-Month Beta 3.02
  • Price/Sales 15.52
  • Price/Cash Flow N/A
  • Price/Book 3.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.93
  • Number of Estimates 7
  • High Estimate -0.37
  • Low Estimate -1.27
  • Prior Year -1.34
  • Growth Rate Est. (year over year) +30.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.61 +0.38%
on 03/07/19
22.57 -17.24%
on 02/20/19
-3.47 (-15.67%)
since 02/19/19
3-Month
9.87 +89.26%
on 02/04/19
32.32 -42.20%
on 02/06/19
+5.90 (+46.17%)
since 12/19/18
52-Week
9.87 +89.26%
on 02/04/19
32.32 -42.20%
on 02/06/19
-10.51 (-36.01%)
since 03/19/18

Most Recent Stories

More News
MacroGenics to Participate in Upcoming Investor Conferences

EQNX::TICKER_START (NASDAQ:MGNX), EQNX::TICKER_END

MGNX : 18.81 (-1.42%)
Global Biotech Market Primed for Growth With Renewed Research and Development Efforts

Diseases are commonplace around the world, especially in regions that don't have access to adequate healthcare. They present themselves as various groups such as cancers, diabetes, skin, bacterial, as...

MGNX : 18.81 (-1.42%)
VYGR : 18.29 (-3.23%)
ZLAB : 30.43 (+1.77%)
PRTA : 14.31 (-1.24%)
ABBV : 80.92 (+0.33%)
XBIT : 10.32 (+4.88%)
PBIO : 3.1900 (-2.45%)
IMMU : 18.66 (-0.96%)
SmarTrend Watching for Potential Rebound in Shares of Macrogenics Inc After 3.96% Loss

Macrogenics Inc (NASDAQ:MGNX) traded in a range yesterday that spanned from a low of $20.87 to a high of $21.52. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $21.15...

MGNX : 18.81 (-1.42%)
MacroGenics Announces Participation in SVB Leerink Global Healthcare Conference

EQNX::TICKER_START (NASDAQ:MGNX), EQNX::TICKER_END

MGNX : 18.81 (-1.42%)
Frontier Communications' (FTR) Q4 Earnings: What's in Store?

Soft demand pattern in voice and video businesses, along with decline in switched access are likely to take a toll on Frontier Communications' (FTR) fourth-quarter revenues.

MGNX : 18.81 (-1.42%)
TBPH : 23.58 (-2.08%)
FTR : 2.50 (-1.19%)
LYV : 62.98 (-0.16%)
Key Factors to Know Ahead of TransEnterix (TRXC) Q4 Earnings

TransEnterix (TRXC) is anticipated to witness robust top-line growth in Q4 on the back of multiple product developments.

MGNX : 18.81 (-1.42%)
TGTX : 7.25 (-2.16%)
BDSI : 4.89 (-0.41%)
TRXC : 2.28 (-2.98%)
MacroGenics Announces Date of Fourth Quarter and Full Year 2018 Financial Results Conference Call

EQNX::TICKER_START (NASDAQ:MGNX), EQNX::TICKER_END

MGNX : 18.81 (-1.42%)
Will Leasing Support SBA Communications' (SBAC) Q4 Earnings?

Solid domestic site leasing business, excellent services and cost control initiatives are likely to drive SBA Communications' (SBAC) fourth-quarter earnings.

MGNX : 18.81 (-1.42%)
TBPH : 23.58 (-2.08%)
SBAC : 192.60 (+0.54%)
LYV : 62.98 (-0.16%)
HMS Holdings (HMSY) to Report Q4 Earnings: What's in Store?

HMS Holdings (HMSY) expects to gain from its total population management or TPM business in fourth-quarter 2018.

MGNX : 18.81 (-1.42%)
TGTX : 7.25 (-2.16%)
MASI : 133.28 (+0.77%)
HMSY : 32.86 (+0.55%)
What's in Store for Telefonica Brasil (VIV) in Q4 Earnings?

Telefonica Brasil's (VIV) fourth-quarter earnings are likely to benefit from its asset base and solid position in key high-value segments.

MGNX : 18.81 (-1.42%)
TBPH : 23.58 (-2.08%)
VIV : 12.79 (+0.16%)
LYV : 62.98 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade MGNX with:

Business Summary

MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics...

See More

Key Turning Points

2nd Resistance Point 19.55
1st Resistance Point 19.32
Last Price 18.81
1st Support Level 18.91
2nd Support Level 18.73

See More

52-Week High 32.32
Fibonacci 61.8% 23.74
Fibonacci 50% 21.09
Last Price 18.81
Fibonacci 38.2% 18.45
52-Week Low 9.87

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar